Top Key Companies for Next Generation Sequencing Market: 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar.
Global Next Generation Sequencing Market Research Report: 2025-2032 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Next Generation Sequencing Market Overview And Scope:
The Global Next Generation Sequencing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Next Generation Sequencing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Next Generation Sequencing Market Segmentation
By Type, Next Generation Sequencing market has been segmented into:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
By Application, Next Generation Sequencing market has been segmented into:
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Regional Analysis of Next Generation Sequencing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Next Generation Sequencing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Next Generation Sequencing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Next Generation Sequencing market.
Top Key Companies Covered in Next Generation Sequencing market are:
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters
Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Key Questions answered in the Next Generation Sequencing Market Report:
1. What is the expected Next Generation Sequencing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Next Generation Sequencing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Next Generation Sequencing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Next Generation Sequencing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Next Generation Sequencing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Next Generation Sequencing Markets?
7. How is the funding and investment landscape in the Next Generation Sequencing Market?
8. Which are the leading consortiums and associations in the Next Generation Sequencing Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Next Generation Sequencing Market by Type
5.1 Next Generation Sequencing Market Overview Snapshot and Growth Engine
5.2 Next Generation Sequencing Market Overview
5.3 Targeted Sequencing & Resequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Targeted Sequencing & Resequencing: Geographic Segmentation
5.4 Whole Genome Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Whole Genome Sequencing: Geographic Segmentation
5.5 Whole Exome Sequencing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Whole Exome Sequencing: Geographic Segmentation
Chapter 6: Next Generation Sequencing Market by Application
6.1 Next Generation Sequencing Market Overview Snapshot and Growth Engine
6.2 Next Generation Sequencing Market Overview
6.3 Whole-genome Sequencing
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Whole-genome Sequencing: Geographic Segmentation
6.4 Exome Sequencing
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Exome Sequencing: Geographic Segmentation
6.5 Targeted Resequencing
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Targeted Resequencing: Geographic Segmentation
6.6 De Novo Sequencing
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 De Novo Sequencing: Geographic Segmentation
6.7 RNA Sequencing
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 RNA Sequencing: Geographic Segmentation
6.8 ChIP Sequencing
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 ChIP Sequencing: Geographic Segmentation
6.9 Methyl Sequencing
6.9.1 Introduction and Market Overview
6.9.2 Historic and Forecasted Market Size (2017-2032F)
6.9.3 Key Market Trends, Growth Factors and Opportunities
6.9.4 Methyl Sequencing: Geographic Segmentation
6.10 Others
6.10.1 Introduction and Market Overview
6.10.2 Historic and Forecasted Market Size (2017-2032F)
6.10.3 Key Market Trends, Growth Factors and Opportunities
6.10.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Next Generation Sequencing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Next Generation Sequencing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Next Generation Sequencing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 454 LIFE SCIENCES CORPORATION (A ROCHE COMPANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 AGILENT TECHNOLOGIES
7.4 BIOMATTERS
7.5 LTD
7.6 CLC BIO
7.7 GATC BIOTECH AG
7.8 MACROGEN
7.9 BGI (BEIJING GENOMICS INSTITUTE)
7.10 ILLUMINA
7.11 LIFE TECHNOLOGY CORPORATION
7.12 EMC CORPORATION
7.13 DNASTAR
Chapter 8: Global Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Targeted Sequencing & Resequencing
8.2.2 Whole Genome Sequencing
8.2.3 Whole Exome Sequencing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Whole-genome Sequencing
8.3.2 Exome Sequencing
8.3.3 Targeted Resequencing
8.3.4 De Novo Sequencing
8.3.5 RNA Sequencing
8.3.6 ChIP Sequencing
8.3.7 Methyl Sequencing
8.3.8 Others
Chapter 9: North America Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Targeted Sequencing & Resequencing
9.4.2 Whole Genome Sequencing
9.4.3 Whole Exome Sequencing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Whole-genome Sequencing
9.5.2 Exome Sequencing
9.5.3 Targeted Resequencing
9.5.4 De Novo Sequencing
9.5.5 RNA Sequencing
9.5.6 ChIP Sequencing
9.5.7 Methyl Sequencing
9.5.8 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Targeted Sequencing & Resequencing
10.4.2 Whole Genome Sequencing
10.4.3 Whole Exome Sequencing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Whole-genome Sequencing
10.5.2 Exome Sequencing
10.5.3 Targeted Resequencing
10.5.4 De Novo Sequencing
10.5.5 RNA Sequencing
10.5.6 ChIP Sequencing
10.5.7 Methyl Sequencing
10.5.8 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Targeted Sequencing & Resequencing
11.4.2 Whole Genome Sequencing
11.4.3 Whole Exome Sequencing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Whole-genome Sequencing
11.5.2 Exome Sequencing
11.5.3 Targeted Resequencing
11.5.4 De Novo Sequencing
11.5.5 RNA Sequencing
11.5.6 ChIP Sequencing
11.5.7 Methyl Sequencing
11.5.8 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Targeted Sequencing & Resequencing
12.4.2 Whole Genome Sequencing
12.4.3 Whole Exome Sequencing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Whole-genome Sequencing
12.5.2 Exome Sequencing
12.5.3 Targeted Resequencing
12.5.4 De Novo Sequencing
12.5.5 RNA Sequencing
12.5.6 ChIP Sequencing
12.5.7 Methyl Sequencing
12.5.8 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Targeted Sequencing & Resequencing
13.4.2 Whole Genome Sequencing
13.4.3 Whole Exome Sequencing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Whole-genome Sequencing
13.5.2 Exome Sequencing
13.5.3 Targeted Resequencing
13.5.4 De Novo Sequencing
13.5.5 RNA Sequencing
13.5.6 ChIP Sequencing
13.5.7 Methyl Sequencing
13.5.8 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Next Generation Sequencing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Targeted Sequencing & Resequencing
14.4.2 Whole Genome Sequencing
14.4.3 Whole Exome Sequencing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Whole-genome Sequencing
14.5.2 Exome Sequencing
14.5.3 Targeted Resequencing
14.5.4 De Novo Sequencing
14.5.5 RNA Sequencing
14.5.6 ChIP Sequencing
14.5.7 Methyl Sequencing
14.5.8 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Next Generation Sequencing Scope:
|
Report Data
|
Next Generation Sequencing Market
|
|
Next Generation Sequencing Market Size in 2025
|
USD XX million
|
|
Next Generation Sequencing CAGR 2025 - 2032
|
XX%
|
|
Next Generation Sequencing Base Year
|
2024
|
|
Next Generation Sequencing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar.
|
|
Key Segments
|
By Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
By Applications
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
|
